Speech Transitioning to Value-Based Oncology: Strategies to Survive and Thrive

Transitioning to Value-Based Oncology: Strategies to Survive and Thrive

The healthcare payment landscape continues to change rapidly for oncology practices as reimbursement trends downward and payors shift from fee-for-service to value-based models. With market forces driving clinical integration and consolidation, oncology providers are being offered opportunities to participate in an array of new delivery arrangements, including ACOs, patient-centered medical homes (PCMHs), integrated delivery systems, and limited/exclusive provider networks. This session will explore a range of organizational and structural options available to oncology programs that will help them position themselves for future success in this evolving healthcare environment. Some of the strategic options examined include clinical affiliation arrangements, practice acquisition/direct employment, Professional Services Agreements, oncology medical homes, oncology supergroups and super independent practice associations (IPAs), contracts with ACOs, PCMHs and integrated delivery systems, private equity joint venture structures, and hospital-based cancer service line participation.